default author photo

Surbhi Sidana

Stanford Medicine

Stanford, CA

United States

SCHOLARLY PAPERS

1

DOWNLOADS

45

TOTAL CITATIONS

0

Scholarly Papers (1)

1.

FORTRESS-CART: Focused Observation and Risk Testing for Robust Evaluation of Safety in Chimeric Antigen Receptor T-cell Therapy (CAR-T): Real-World Predictors of Second Primary Malignancies (SPMs) Among Patients Treated with CAR-T

Number of pages: 39 Posted: 08 Sep 2025
Mayo Clinic, Stanford Medicine, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Analysis Group, affiliation not provided to SSRN, affiliation not provided to SSRN and affiliation not provided to SSRN
Downloads 45 (1,121,190)

Abstract:

Loading...

CAR-T Cell Therapy, second primary malignancies, adverse events, Risk factors, Multiple myeloma, lymphoma, Leukemia